Page 184 - Eshre Final Programme 2015
P. 184
P-166 Crucial role of hypoxia inducible factor 2alpha in the pregnant uterus
L. Matsumoto1, Y. Hirota1, T. Saito-Fujita1, H. Haraguchi1, M. Egashira1, M. Matsuo1, T. Hiraoka1, T. Tanaka1, N. Takeda2, T. Fujii1, Y. Osuga1
1The University of Tokyo, Obstetrics and Gynecology, Tokyo, Japan 2The University of Tokyo, Cardiovascular Medicine, Tokyo, Japan
P-167 Pregnancy of unknown location (PUL): prevalence and clinical outcome
A. Malik1, K. Jayaprakasan1, D.P. Hay1, J. Dasgupta1
1Royal Derby Hospital, Obstetric and Gynaecology, Derby, United Kingdom
P-168 Peri-conceptional Progesterone treatment in women with unexplained recurrent miscarriage, A randomized double-blind controlled trial
A. Ismail1, A. Nasr1, A. Amin1, H. Al-Inany2
1Assuit University, Obstetrics & Gynecology, Assuit, Egypt 2Cairo University, Obstetrics & Gynecology, Cairo, Egypt
P-169 Increased expression of Plasminogen-Activator-Inhibitor Type 1 (PAI-1) in the sera of patients with recurrent miscarriages (RM) and anti-trophoblast antibodies (ATAB)
V. Von Schönfeldt1, N. Rogenhofer1, K. Friese1, U. Jeschke1, C.J. Thaler1
1Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe der Ludwig Maximillians Universität, Hormon- & Kinderwunschzentrum, München, Germany
P-170 Patient-centered care for couples faced with early pregnancy complications: a systematic review of the literature.
M. Van den Berg1, E.A.F. Dancet1, F. Van der Veen1, M. Goddijn1, P.J. Hajenius2
1Academic Medical Centre, Centre for Reproductive Medicine, Amsterdam, The Netherlands 2Academic Medical Centre, Obstetrics and Gynaecology, Amsterdam, The Netherlands
184


































































































   182   183   184   185   186